About EnWave (CVE:ENW)
EnWave Corporation, an industrial technology company, licenses, builds, and installs commercial-scale dehydration platforms for applications in the food, pharmaceutical, and industrial sectors to manufacturing companies in Canada. The company offers food industry radiant energy vacuum (REV) platforms, such as nutraREV to dehydrate fruits, vegetables, herbs, dairy products, meats, and seafood products; and quantaREV to dehydrate solid, liquid, granular, or encapsulated food or industrial products. It also provides pharmaceutical industry REV platforms, including powderREV for the bulk dehydration of temperature-sensitive biomaterials, such as probiotics and enzymes; and freezeREV for the dehydration of biomaterial and pharmaceutical products. The company is headquartered in Vancouver, Canada.
Industry, Sector and Symbol:
- Industry: Diversified Machinery
- Sub-Industry: N/A
- Sector: Industrial Goods
- Symbol: CVE:ENW
- CUSIP: N/A
- Web: www.enwave.net
- Trailing EPS: C($0.04)
- Net Margins: -11.32%
- Return on Equity: -26.45%
- Return on Assets: -15.00%
- Outstanding Shares: 90,829,000
Frequently Asked Questions for EnWave (CVE:ENW)
What is EnWave's stock symbol?
EnWave trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ENW."
When will EnWave make its next earnings announcement?
Who are some of EnWave's key competitors?
Some companies that are related to EnWave include Abengoa SA (ABGBY), Conifex Timber (CFF), Stuart Olson (SOX), Atlantis Resources Ltd (ARL), WesternOne (WEQ), Accsys Technologies PLC (AXS), Ceradyne (CRDN), COMPAGNIE DE SAINT-GOBAIN COMPAGNIE DE ST-GOBAIN (COD), GRAFTON GROUP PLC UT (1 ORD, 1 C (GFTU), MJ Gleeson PLC (GLE) and WCA Waste (WCAA).
Who are EnWave's key executives?
EnWave's management team includes the folowing people:
- John P. A. Budreski, Executive Chairman of the Board
- Timothy D. Durance, President, Chief Executive Officer, Director
- Daniel Stephen Henriques, Chief Financial Officer
- Brent Charleton, Senior Vice President of Sales and Business Development
- Richard Mitchell, Senior Vice President - Pharmaceutical Business Development
- Hugh Crawford McKinnon, Independent Director
- Mary C. Ritchie, Independent Director
- Stewart John Ritchie, Independent Director
- Gary Sandberg Ph.D., Independent Director
How do I buy EnWave stock?
Shares of EnWave and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is EnWave's stock price today?
One share of EnWave stock can currently be purchased for approximately C$1.06.
How big of a company is EnWave?
EnWave has a market capitalization of C$97.19 million.
How can I contact EnWave?
MarketBeat Community Rating for EnWave (CVE ENW)MarketBeat's community ratings are surveys of what our community members think about EnWave and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
EnWave's mailing address is 744 Hastings St W, VANCOUVER, BC V6C 1A5, Canada. The company can be reached via phone at +1-604-8355212.
Analysts' Consensus Ratings for EnWave (CVE:ENW) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|Consensus Price Target History for EnWave (CVE:ENW)
Analysts' Ratings History for EnWave (CVE:ENW)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for EnWave (CVE:ENW)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for EnWave (CVE:ENW)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for EnWave (CVE:ENW)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for EnWave (CVE ENW)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for EnWave (CVE:ENW)
Latest Headlines for EnWave (CVE ENW)
Financials are not available for this stock.
EnWave (CVE ENW) Chart for Friday, November, 17, 2017